Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $25,560 | 8 | 71.9% |
| Travel and Lodging | $5,021 | 12 | 14.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 2 | 8.4% |
| Food and Beverage | $1,547 | 16 | 4.4% |
| Education | $409.39 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $10,326 | 14 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $8,817 | 8 | $0 (2018) |
| AstraZeneca UK Limited | $4,600 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $3,001 | 5 | $0 (2019) |
| VENTANA MEDICAL SYSTEMS, INC. | $2,609 | 6 | $0 (2019) |
| Gilead Sciences, Inc. | $1,845 | 2 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $1,750 | 1 | $0 (2024) |
| Exelixis Inc. | $1,500 | 1 | $0 (2019) |
| Daiichi Sankyo Inc. | $1,090 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,750 | 1 | Bayer Healthcare Pharmaceuticals Inc. ($1,750) |
| 2023 | $1,090 | 1 | Daiichi Sankyo Inc. ($1,090) |
| 2019 | $5,668 | 10 | VENTANA MEDICAL SYSTEMS, INC. ($2,609) |
| 2018 | $15,994 | 20 | Merck Sharp & Dohme Corporation ($10,326) |
| 2017 | $11,036 | 7 | Novartis Pharmaceuticals Corporation ($6,436) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Consulting Fee | Cash or cash equivalent | $1,750.00 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $1,090.00 | General |
| 08/14/2019 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $535.50 | General |
| 08/14/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $23.05 | General |
| 07/17/2019 | Exelixis Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| 04/24/2019 | VENTANA MEDICAL SYSTEMS, INC. | VENTANA RESEARCH & DEVELOPMENT (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Tissue Diagnostics | ||||||
| 04/24/2019 | VENTANA MEDICAL SYSTEMS, INC. | VENTANA RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $494.85 | General |
| Category: Tissue Diagnostics | ||||||
| 04/24/2019 | VENTANA MEDICAL SYSTEMS, INC. | VENTANA RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $24.00 | General |
| Category: Tissue Diagnostics | ||||||
| 04/10/2019 | VENTANA MEDICAL SYSTEMS, INC. | VENTANA RESEARCH & DEVELOPMENT (Device) | Education | In-kind items and services | $409.39 | General |
| Category: Tissue Diagnostics | ||||||
| 04/10/2019 | VENTANA MEDICAL SYSTEMS, INC. | VENTANA RESEARCH & DEVELOPMENT (Device) | Travel and Lodging | In-kind items and services | $140.00 | General |
| Category: Tissue Diagnostics | ||||||
| 04/10/2019 | VENTANA MEDICAL SYSTEMS, INC. | VENTANA RESEARCH & DEVELOPMENT (Device) | Food and Beverage | In-kind items and services | $41.00 | General |
| Category: Tissue Diagnostics | ||||||
| 01/03/2019 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 11/14/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $285.46 | General |
| 10/08/2018 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $1,556.00 | General |
| 10/08/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $600.88 | General |
| 09/21/2018 | Gilead Sciences, Inc. | — | Travel and Lodging | In-kind items and services | $845.03 | General |
| 06/29/2018 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $9,000.00 | General |
| 06/29/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 06/01/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Consulting Fee | Cash or cash equivalent | $2,320.00 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $60.70 | General |
| Category: ONCOLOGY | ||||||
| 05/02/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $47.11 | General |
| 05/02/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 05/02/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.86 | General |
| 05/02/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.78 | General |
| 05/01/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $295.29 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 25 | 28 | $35,277 | $3,057 |
| 2021 | 2 | 27 | 27 | $74,469 | $6,502 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Facility | 2022 | 12 | 15 | $15,160 | $1,585 | 10.5% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 13 | 13 | $20,117 | $1,473 | 7.3% |
| 38525 | Biopsy or removal of lymph nodes of under the arm, open procedure | Facility | 2021 | 12 | 12 | $51,921 | $4,786 | 9.2% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 15 | 15 | $22,548 | $1,716 | 7.6% |
About Dr. Jennifer Wargo, MD
Dr. Jennifer Wargo, MD is a Surgery healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861465437.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Wargo, MD has received a total of $35,538 in payments from pharmaceutical and medical device companies, with $1,750 received in 2024. These payments were reported across 39 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($25,560).
As a Medicare-enrolled provider, Wargo has provided services to 52 Medicare beneficiaries, totaling 55 services with total Medicare billing of $9,560. Data is available for 2 years (2021–2022), covering 4 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Surgical Oncology
- Location Houston, TX
- Active Since 02/13/2006
- Last Updated 03/26/2014
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1861465437
Products in Payments
- MEKINIST (Drug) $5,174
- TAFINLAR (Drug) $3,547
- VENTANA RESEARCH & DEVELOPMENT (Device) $2,609
- Nubeqa (Drug) $1,750
- BINIMETINIB (Drug) $96.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Houston
Samir Awad, Md, MD
Surgery — Payments: $1.5M
Gustavo Oderich, Md, MD
Surgery — Payments: $568,544
Ali Azizzadeh Fard, M.d, M.D
Surgery — Payments: $334,137
Dr. Robert Southard, Md, MD
Surgery — Payments: $305,944
Omar Barakat, Md, MD
Surgery — Payments: $279,155
Dr. Edward Chang, M.d, M.D
Surgery — Payments: $181,536